Biomedical Engineering and Data Science

The scientific program of Biomedical Engineering and Data Science focuses on the integration of advanced technologies to address key challenges in biomedical research and clinical practice. These disciplines are revolutionizing the diagnosis, treatment, monitoring, and rehabilitation of patients, having a significant impact on the sustainability and quality of healthcare systems.

Over the past decade, significant advances have been made in technologies such as artificial intelligence, nanomaterials, medical devices, and computational modeling, enabling a more personalized and efficient approach to healthcare. Notable innovations include the creation of digital twins to assess arrhythmic risk; the development of therapeutic nanoparticles, which enable precise drug delivery to specific tissues; and controlled drug-release platforms, which are transforming the treatment of complex diseases such as cardiovascular disease, cancer, and bacterial infections.

The program also prioritizes the transfer of knowledge and technology to the industrial sector, facilitating the creation of spin-offs, patents, and strategic collaborations that guarantee the implementation of these innovations in the National Health System (NHS). It also addresses critical areas such as personalized medicine, with predictive tools based on patient-specific data, and remote monitoring using wearable devices, which optimize the management of chronic diseases and reduce healthcare costs.

Interdisciplinary collaboration is a fundamental pillar, with groups combining expertise in biomedical engineering, computational biology, and clinical sciences to address problems of high socioeconomic impact. Through translational projects, the goal is not only to improve health outcomes but also to provide sustainable solutions to current challenges arising from the aging population and the increase in chronic diseases.

Finally, the program incorporates a gender and diversity perspective by integrating sex and gender analysis into research, increasing its value and social impact and incorporating an inclusive and equitable approach. These strategies position the program as a benchmark in biomedical innovation and data science, driving scientific excellence and its impact on society.

The program coordinator is Dr. Ana Mincholé Lapuente